Evaluation of the efficiency of photobiomodulation in the prevention of oral mucositis? in chemotherapy-treated cancer patients

Phase 3

• Conditions: Prevention of oral mucositis? in chemotherapy-treated cancer patients; Oral Health

• Registration Number: ISRCTN70634383
• Lead Sponsor: Damascus University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-24
• Last Update Posted: 7 August 2023
• Study Completion: 2024-02-18

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Cancer patients undergoing chemotherapy for the first time with the same risk of mucositis:
1. Solid tumor patients
1.1. Chemotherapy (5-Fluorouracil) intravenously or orally
1.2. Neutrophil count = 1500 cells/µL
1.3. Platelet count = 100,000/µl
1.4. A healthy oral mucosa
1.5. Karnofsky performance status index >60

Exclusion Criteria

1. Radiotherapy in the head and neck area
2. Malignant or potentially malignant lesions of the oral cavity
3. Oral infections
4. Oral bleeding
5. Undergoing any other measures to prevent oral mucositis
6. Patients unable to commit to the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified